RxDoctor Payments Data

James Blotter, MD

Plastic Surgery within the Head & Neck · North Logan, UTNPI 1962499673

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,343 of the $1,742 with a category attached, or 77.1%. 20 manufacturers reported payments, led by Medtronic at 27.5% of the total. Reporting peaked in 2020 at $552 and has fallen 61.6% since, to $212 in 2025.

$1,742in general payments, 2019–2025

Across 72 payments — averaging $24.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$479
  • AbbVie$175
  • AstraZeneca$174
  • Pharming Healthcare, Inc.$147
  • Amgen$143
  • Boston Scientific$92
  • plus $533 from 14 others
$5,668in research payments, 2019–2025

Across 2 payments — averaging $2833.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$6K

What the payments were for

  • Travel & lodging$39923%
  • Food & beverage$1,34377%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$69,009
Medicare patients
235
Services billed
1,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$57,382
SynthroidLevothyroxine Sodium39$3,265
Famotidine84$1,406
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,148
Fluticasone Propionate52$945
Omeprazole55$906
Esomeprazole Magnesium17$638
Ipratropium Bromide27$582
Levothyroxine Sodium77$562
Montelukast Sodium57$542
Calcitriol11$422
Liothyronine Sodium18$421
Mupirocin43$355
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$254
Triamcinolone Acetonide11$234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$175$3,26539 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few plastic surgery within the head & neck providers in Utahon file to place this against a meaningful peer group, so we don't.

Other plastic surgery within the head & neck in North Logan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →